secwatch.observer — SEC 8-K summary
======================================

Issuer:     AYTU BIOPHARMA, INC (AYTU)
CIK:        0001385818
Form:       8-K
Filed at:   2022-12-27T23:59:59+00:00
Accession:  0001558370-22-018991
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Gary Cantrell to retire from Aytu BioPharma board effective Dec. 31, 2022
--------------------------------------------------------------------------------

- Gary Cantrell notified Aytu BioPharma of his intention to retire from the Board, effective December 31, 2022.
- Mr. Cantrell did not advise the Company of any disagreement with its operations, policies, or practices.
- Aytu is initiating a search for an additional member of the Board of Directors.
- The retirement is a planned departure, not due to any dispute or controversy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1385818/000155837022018991/0001558370-22-018991-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1385818/000155837022018991/aytu-20221222x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-018991

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer